BridgeMD
New treatment option for Tourette Syndrome
Official title Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome With or Without Biofeedback
ClinicalTrials.gov ID: NCT06873841
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the effectiveness of CoPs therapy with or without the therapeutic component of biofeedback in treating tics in Tourette Syndrome with emerging young adults. Hypotheses: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 21
You may be able to join if
- Have a diagnosis of TS or to experience bothersome tics;
- Be aged 14 to 21 years inclusive at the start of therapy.
You likely can't join if
- Present a sensorimotor impairment;
- Have a diagnosis of intellectual disability (intelligence quotient below 75);
- Alcohol or drug abuse;
- A neurological issue (e.g., hemifacial spasms, Huntington's disease);
- Change medication one month or less before step 1 and up to step 4 (last measurement time) without informing a member of the research team;
- Simultaneously receive another intervention for tics (e.g., psychologist, massage therapist) without informing a research team member.
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.